Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Synthesis and angiotension converting enzyme inhibitory activity of L-lysyl-N-substituted glycine derivatives.

Saito S, Matsui S, Fukushima S, Watanabe M, Waga T, Kajiwara Y, Shirota M, Iijima M, Kitabatake K.

Arzneimittelforschung. 1989 Dec;39(12):1558-61.

PMID:
2560371
2.
3.

Inhibition of angiotensin converting enzyme by CV-3317, a non-sulfhydryl compound.

Inada Y, Terashita Z, Imura Y, Tanabe M, Nishikawa K, Kikuchi S.

Jpn J Pharmacol. 1986 Sep;42(1):99-108.

4.

Synthesis and angiotensin converting enzyme inhibitory activity of N-carboxymethyldipeptides with an omega-aminoalkyl group.

Saito S, Matsui S, Watanabe M, Waga T, Kajiwara Y, Shirota M, Iijima M, Kitabatake K.

Arzneimittelforschung. 1990 Mar;40(3):257-60.

PMID:
2346534
5.

Inhibitory activity and protein binding of L-lysine derivatives as angiotensin converting enzyme inhibitors.

Saito S, Matsui S, Watanabe M, Waga T, Kajiwara Y, Shirota M, Iijima M, Kitabatake K, Matsushita Y, Moriguchi I.

Arzneimittelforschung. 1990 Oct;40(10):1078-81.

PMID:
1963299
6.

Angiotensin-converting enzyme inhibitors: synthesis and biological activity of N-substituted tripeptide inhibitors.

Sawayama T, Tsukamoto M, Sasagawa T, Nishimura K, Deguchi T, Takeyama K, Hosoki K.

Chem Pharm Bull (Tokyo). 1990 Jan;38(1):110-5.

PMID:
2159850
7.

Synthesis and angiotensin converting enzyme inhibitory activity of N-carboxymethyldipeptides with omega-(4-piperidyl)alkyl group.

Waga T, Matsui S, Saito S, Watanabe M, Kajiwara Y, Shirota M, Iijima M, Kitabatake K.

Arzneimittelforschung. 1990 Apr;40(4):407-13.

PMID:
2162675
9.

New dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme: rational design, bioavailability, and pharmacological responses in experimental hypertension.

FourniƩ-Zaluski MC, Coric P, Turcaud S, Rousselet N, Gonzalez W, Barbe B, Pham I, Jullian N, Michel JB, Roques BP.

J Med Chem. 1994 Apr 15;37(8):1070-83.

PMID:
8164250
10.

[Inhibitory effect of N-alpha-[(S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline (MK-0521) on angiotensin converting enzyme in vitro].

Ino Y, Oda M, Sato T, Iwaki M.

Nihon Yakurigaku Zasshi. 1989 Apr;93(4):219-24. Japanese.

PMID:
2545578
11.

Angiotensin converting enzyme inhibitors: N-substituted monocyclic and bicyclic amino acid derivatives.

Stanton JL, Gruenfeld N, Babiarz JE, Ackerman MH, Friedmann RC, Yuan AM, Macchia W.

J Med Chem. 1983 Sep;26(9):1267-77.

PMID:
6310112
12.

Synthesis and pharmacological activity of angiotensin converting enzyme inhibitors: N-(mercaptoacyl)-4-substituted-(S)-prolines.

Smith EM, Swiss GF, Neustadt BR, Gold EH, Sommer JA, Brown AD, Chiu PJ, Moran R, Sybertz EJ, Baum T.

J Med Chem. 1988 Apr;31(4):875-85.

PMID:
2832605
13.

Evidence for the negative cooperativity of the two active sites within bovine somatic angiotensin-converting enzyme.

Binevski PV, Sizova EA, Pozdnev VF, Kost OA.

FEBS Lett. 2003 Aug 28;550(1-3):84-8.

14.
15.

Angiotensin converting enzyme inhibitors: spirapril and related compounds.

Smith EM, Swiss GF, Neustadt BR, McNamara P, Gold EH, Sybertz EJ, Baum T.

J Med Chem. 1989 Jul;32(7):1600-6.

PMID:
2544729
16.

(Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme. 2. Terminal amino acid analogues of (S)-1-[6-amino-2 [[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L-proline.

Karanewsky DS, Badia MC, Cushman DW, DeForrest JM, Dejneka T, Lee VG, Loots MJ, Petrillo EW.

J Med Chem. 1990 May;33(5):1459-69.

PMID:
2329568
17.

Angiotensin-converting enzyme inhibitors. 9. Novel [[N-(1-carboxy-3-phenylpropyl)amino]acyl]glycine derivatives with diuretic activity.

Barton JN, Piwinski JJ, Skiles JW, Regan JR, Menard PR, Desai R, Golec FS, Reilly LW, Goetzen T, Ueng SN, et al.

J Med Chem. 1990 Jun;33(6):1600-6.

PMID:
2342054
18.

Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.

Gross DM, Sweet CS, Ulm EH, Backlund EP, Morris AA, Weitz D, Bohn DL, Wenger HC, Vassil TC, Stone CA.

J Pharmacol Exp Ther. 1981 Mar;216(3):552-7.

PMID:
6259322
19.

Synthesis and biological properties of (carboxyalkyl)amino-substituted bicyclic lactam inhibitors of angiotensin converting enzyme.

Watthey JW, Stanton JL, Desai M, Babiarz JE, Finn BM.

J Med Chem. 1985 Oct;28(10):1511-6.

PMID:
2995669
20.

Synthesis and angiotensin converting enzyme-inhibitory activity of N-[(1S)-1-carboxy-5-(4-piperidyl)pentyl]-L-alanine derivatives.

Kori M, Itoh K, Inada Y, Katoh T, Sumino Y, Nishikawa K, Sugihara H.

Chem Pharm Bull (Tokyo). 1994 Mar;42(3):580-5.

PMID:
8004703
Items per page

Supplemental Content

Support Center